Diabetes affects approximately 3.7 million people, with more than 200,000 new cases diagnosed every year, making it one of the most common chronic diseases in Canada. This Diabetes Awareness Month… Read More
VANCOUVER, BC — Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, and Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”), a special purpose acquisition company (“SPAC”),… Read More
Innovative Medicines Canada (IMC) is pleased to announce that Brigitte Nolet, President and CEO of Roche Canada Pharma, has been selected as Chair of its Board of Directors. “Brigitte has… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, reports financial… Read More
BURNABY, BC — Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce… Read More
